OncLive SOSS

Advancing Treatments for Bladder Cancer: Insights from ASCO GU 2024 - Episode 4

Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

March 4, 2024

Elizabeth R. Plimack, MD, MS, FASCO, Neeraj Agarwal, MD, Matthew Milowsky, MD, FASCO, Evan Y. Yu, MD

Experts on muscle-invasive bladder cancer respond to recent data in adjuvant therapy that were presented at ASCO GU 2024.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer (MIBC)

EP. 2: Ongoing Research on Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer

EP. 3: Recent Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

EP. 4: Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

EP. 5: Emerging Data in Metastatic Urothelial Carcinoma

EP. 6: Clinical Insights on Recent Data in Metastatic Urothelial Carcinoma

EP. 7: Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma

EP. 8: Later-Line Therapies for Metastatic Urothelial Carcinoma

EP. 9: Treatment Sequencing Practices in Metastatic Urothelial Carcinoma

EP. 10: Exciting New Approaches in Metastatic Urothelial Carcinoma

EP. 11: Key Takeaways on Updates in Bladder Cancer

x